Cardiovascular Safety of ADHD Medication Treatments Final Test

1. In 2006, an FDA review of the safety of psychostimulant medications found that the primary reason for sudden death in a few ADHD patients was:

2. A meta-analysis of studies of adults taking ADHD stimulant medications vs placebo showed notable changes in:

3. FDA-approved non-stimulant medications have been shown to be effective in treating the symptoms of ADHD. These non-stimulant medications include all except:

4. Cardio-vascular risk (ie fainting, hypertension, heart disease, family history, smoking) should be screened for thoroughly prior to using which ADHD medications:

5. In ADHD patients who have cleared screening for cardiovascular risk, there is little concern about using stimulant medications.

6. What is the most commonly prescribed medication for treatment of ADHD in adults?:

7. A positive screen for cardiovascular risk in an ADHD patient should:

8. An ADHD patient with high blood pressure controlled by hypertensive medication should not be put on stimulant medication: